BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17553861)

  • 1. Percutaneous penetration of uranium in rats after a contamination on intact or wounded skin.
    Petitot F; Gautier C; Moreels AM; Frelon S; Paquet F
    Radiat Prot Dosimetry; 2007; 127(1-4):125-30. PubMed ID: 17553861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation and distribution of uranium in rats after a contamination on intact or wounded skin.
    Petitot F; Frelon S; Moreels AM; Claraz M; Delissen O; Tourlonias E; Dhieux B; Maubert C; Paquet F
    Health Phys; 2007 May; 92(5):464-74. PubMed ID: 17429305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USTUR whole body case 0262: 33-y follow-up of PuO2 in a skin wound and associated axillary node.
    James AC; Sasser LB; Stuit DB; Wood TG; Glover SE; Lynch TP; Dagle GE
    Radiat Prot Dosimetry; 2007; 127(1-4):114-9. PubMed ID: 18227076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NCRP wound model: development and application.
    Guilmette RA; Durbin PW; Toohey RE; Bertelli L
    Radiat Prot Dosimetry; 2007; 127(1-4):103-7. PubMed ID: 17766262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of percutaneous diffusion of uranyl nitrate through intact or excoriated skin of rat and pig.
    Petitot F; Moreels AM; Paquet F
    Can J Physiol Pharmacol; 2004 Feb; 82(2):133-9. PubMed ID: 15052294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
    Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
    Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of the percutaneous penetration and distribution of uranyl nitrate as a function of skin-barrier integrity: an in vitro assessment.
    Petitot F; Moreels AM; Paquet F
    Drug Chem Toxicol; 2010 Jul; 33(3):316-24. PubMed ID: 20429805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The work of the CONRAD task group 5.2: research studies on biokinetic models.
    Nosske D; Berkovski V; Birchall A; Blanchardon E; Cantone MC; Davis K; Giussani A; Luciani A; Marsh J; Oeh U; Ratia H; Lopez MA
    Radiat Prot Dosimetry; 2007; 127(1-4):93-6. PubMed ID: 17556343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new formulation containing calixarene molecules as an emergency treatment of uranium skin contamination.
    Spagnul A; Bouvier-Capely C; Phan G; Rebière F; Fattal E
    Health Phys; 2010 Sep; 99(3):430-4. PubMed ID: 20699708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo decrease in uranium diffusion through intact and excoriated pig ear skin by a calixarene nanoemulsion.
    Spagnul A; Bouvier-Capely C; Phan G; Landon G; Tessier C; Suhard D; Rebière F; Agarande M; Fattal E
    Eur J Pharm Biopharm; 2011 Oct; 79(2):258-67. PubMed ID: 21620969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future radionuclide speciation studies in biological media.
    Ansoborlo E; Bion L; Doizi D; Moulin C; Lourenco V; Madic C; Cote G; Van der Lee J; Moulin V
    Radiat Prot Dosimetry; 2007; 127(1-4):97-102. PubMed ID: 17578878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancies between different rat models for the assessment of percutaneous penetration of hazardous substances.
    Korinth G; Göen T; Schaller KH; Drexler H
    Arch Toxicol; 2007 Dec; 81(12):833-40. PubMed ID: 17576541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous accumulation of uranium in the brain of rats.
    Houpert P; Frelon S; Monleau M; Bussy C; Chazel V; Paquet F
    Radiat Prot Dosimetry; 2007; 127(1-4):86-9. PubMed ID: 17526906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of uranium and the removal effects of CBMIDA and EHBP in simulated wounds of rats.
    Fukuda S; Iida H; Ikeda M; Yan X; Xie Y
    Health Phys; 2005 Jul; 89(1):81-8. PubMed ID: 15951694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute toxicity of subcutaneously administered depleted uranium and the effects of CBMIDA in the simulated wounds of rats.
    Fukuda S; Ikeda M; Nakamura M; Yan X; Xie Y
    Health Phys; 2009 Apr; 96(4):483-92. PubMed ID: 19276709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of monitoring data for 239Pu accidentally injected via wound site based on the proposed NCRP wound model.
    Ishigure N
    Radiat Prot Dosimetry; 2007; 127(1-4):108-13. PubMed ID: 17561522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro percutaneous absorption of [(14)C]di-N-butylphthalate in rat.
    Payan JP; Marty JP; Fabry JP; Beydon D; Boudry I; Ferrari E; Canel F; Grandclaude MC; Vincent CM
    Drug Metab Dispos; 2001 Jun; 29(6):843-54. PubMed ID: 11353753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration and daily excretion of uranium in urine of Japanese.
    Tolmachev S; Kuwabara J; Noguchi H
    Health Phys; 2006 Aug; 91(2):144-53. PubMed ID: 16832195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of observed body retention of uranium in natural condition in an average Indian adult with the values predicted by the ICRP biokinetic model.
    Singh IS; Jaiswal DD; Nair S; Vijayagopal P; Bhati S; Garg SP
    Radiat Prot Dosimetry; 2008; 131(4):425-30. PubMed ID: 18801754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertainty analysis of doses from inhalation of depleted uranium.
    Puncher M; Bailey MR; Harrison JD
    Health Phys; 2008 Sep; 95(3):300-9. PubMed ID: 18695411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.